⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Robbins LLP Urges SPRY Stockholders Who Lost Money Investing in ARS Pharmaceuticals Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit
prnewswire.com
SPRY
Pomerantz LLP Alerts Shareholders to Investor Suit Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY
SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SPRY
Kaplan Fox Urges Investors of ARS Pharmaceuticals Inc. (SPRY) with Significant Losses to Seek a Leadership Role Before October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact Levi & Korsinsky
globenewswire.com
SPRY
Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Pomerantz LLP Alerts Shareholders to Investor Suit Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY